Home  |  Contact

UniProtKB/Swiss-Prot P20823: Variant p.Gly574Ser

Hepatocyte nuclear factor 1-alpha
Gene: HNF1A
Variant information

Variant position:  574
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LB/B
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Serine (S) at position 574 (G574S, p.Gly574Ser).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to small size and polar (S)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism:  The Ala-98/Val-98 polymorphism is associated with a reduction in glucose-induced serum C-peptide and insulin responses.
Additional information on the polymorphism described.

Variant description:  In a black African with an atypical form of diabetes; also in an individual with hepatic adenoma and familial early-onset diabetes.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  574
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  631
The length of the canonical sequence.

Location on the sequence:   GLHTPASQATTLHVPSQDPA  G IQHLQPAHRLSASPTVSSSS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         GLHTPASQATTLHVPSQDPAGIQHLQPAHRLSASPTVSSSS

Mouse                         GLHEPPSPATTIHIPSQDPSNIQHLQPAHRLSTSPTVSSSS

Rat                           GLHEPSSPATTIHIPSQDPSNIQHLQPAHRLSTSPTVSSSS

Chicken                       GIHTPVSQAPAIHLQNQDTA-IQHLQSGPRLTPSPAVSSSS

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 631 Hepatocyte nuclear factor 1-alpha
Alternative sequence 120 – 631 Missing. In isoform 8.
Alternative sequence 248 – 631 Missing. In isoform 5.
Alternative sequence 279 – 631 Missing. In isoform 4.
Alternative sequence 495 – 601 Missing. In isoform C.
Alternative sequence 521 – 631 Missing. In isoform 6.
Alternative sequence 543 – 601 Missing. In isoform B.


Literature citations

New isoforms in HNF1A.
Gonzalez Ruano E.; Gonzalez Sarmiento R.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7); VARIANT SER-574;

Submission
SeattleSNPs variation discovery resource;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS LEU-27; VAL-98; ASN-487 AND SER-574;

An automated fluorescent single-strand conformation polymorphism technique for screening mutations in the hepatocyte nuclear factor-1alpha gene (maturity-onset diabetes of the young).
Boutin P.; Chevre J.-C.; Hani E.H.; Gomis R.; Pardini V.C.; Guillausseau P.-J.; Vaxillaire M.; Velho G.; Froguel P.;
Diabetes 46:2108-2109(1997)
Cited for: VARIANTS MODY3; VARIANT ATYPICAL DIABETES SER-574;

Bi-allelic inactivation of TCF1 in hepatic adenomas.
Bluteau O.; Jeannot E.; Bioulac-Sage P.; Marques J.M.; Blanc J.-F.; Bui H.; Beaudoin J.-C.; Franco D.; Balabaud C.; Laurent-Puig P.; Zucman-Rossi J.;
Nat. Genet. 32:312-315(2002)
Cited for: INVOLVEMENT IN HEPATIC ADENOMAS; VARIANTS TYR-127; CYS-165; CYS-206; LEU-206; SER-237; GLY-244; PRO-250; CYS-268; GLU-273; SER-574 AND GLN-583;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.